Credit Agricole S A Emergent Bio Solutions Inc. Transaction History

Credit Agricole S A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$40.6 - $57.2 $365,400 - $514,800	-9,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $1.48 Million - $1.99 Million	-37,000 Reduced 80.43%	9,000 $435,000
Q1 2019 May 14, 2019	SELL	$48.23 - $66.16 $1.64 Million - $2.24 Million	-33,916 Reduced 42.44%	46,000 $2.32 Million
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $667,560 - $878,879	12,000 Added 17.67%	79,916 $4.74 Million
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $1.66 Million - $2.12 Million	31,916 Added 88.66%	67,916 $4.47 Million
Q4 2017 Feb 13, 2018	BUY	$37.77 - $47.75 $377,700 - $477,500	10,000 Added 38.46%	36,000 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $887,640 - $1.05 Million	26,000	26,000 $1.05 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.